Skip to content

Cvergenx vs Oncobit AG

Cvergenx logo

Cvergenx

An innovative leader in cancer molecular diagnostics, delivering personalized radiation therapy to enhance patient outcomes

2 employees · est. 2009 · Tampa, United States

VS
Oncobit AG logo

Oncobit AG

Enabling personalized cancer care

15 employees · est. 2018 · Schlieren, Switzerland

Cvergenx is the older company (2009 vs 2018); Oncobit AG is the larger of the two.

Side-by-Side Comparison

Cvergenx Oncobit AG
Founded
2009 older 2018
Headquarters
Tampa, United States Schlieren, Switzerland
Employees
2 15 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Seed Seed
Total Funding
$225.55K $2.45M
Funding Rounds
1 2
Services
Not tracked yet High-precision cancer monitoring solutions, Personalized cancer care, Therapy-decision support, Innovative cancer-specific monitoring tests
Target Customers
Not tracked yet Physicians, Clinicians, Oncology Diagnostics Companies
Taxonomy
Cancer Molecular DiagnosticsPersonalized Radiation TherapyRadiation TherapyCancer CareAdvanced DiagnosticsPrecision Medicine +7 Personalized Cancer CareMedtechGenomic FingerprintingPersonalized Monitoring TestsTherapy Decision SupportDiagnostic Tests +6
Website
cvergenx.com oncobit.com
Cvergenx logo

About Cvergenx

CVERGENX is a pioneering company in the field of cancer molecular diagnostics, specializing in personalized radiation therapy tailored to optimize patient outcomes. With a strong focus on Biotechnology and Health Care industries, the company, founded in 2009, is headquartered in the United States....

Oncobit AG logo

About Oncobit AG

Oncobit AG, with its slogan "Enabling personalized cancer care," is a promising player in the medtech space, operating at the intersection of Biotechnology and Health Care. Founded in 2018 as a UZH Spin-off, the company is based in Switzerland. Its core mission involves developing cancer-specific ge...

Also comparing in this category

Comparing more than these two?

Get Cvergenx, Oncobit AG and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Cvergenx compare?

A PDF of Cvergenx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Cvergenx was founded in 2009, based in Tampa, United States, with 2 employees. CVERGENX is a pioneering company in the field of cancer molecular diagnostics, specializing in personalized radiation therapy tailored to optimize patient outcomes. With a strong focus on Biotechnolog. Oncobit AG was founded in 2018, based in Schlieren, Switzerland, with 15 employees. Oncobit AG, with its slogan "Enabling personalized cancer care," is a promising player in the medtech space, operating at the intersection of Biotechnology and Health Care. Founded in 2018 as a UZH Sp.
Cvergenx has raised $225.55K and Oncobit AG $2.45M. Latest stage: Cvergenx Seed, Oncobit AG Seed.
Both work in Biotechnology and Health Care and list precision medicine among their focus areas.

Compare Cvergenx with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cvergenx on 14 Sep 2024, and Oncobit AG on 15 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout